Singapore HSA Extends Electronic Labelling to P and GSL Medicines

Singapore HSA Therapeutic Products Branch has extended the application of electronic labelling (e-labelling) to Pharmacy-only (P) and General Sale List …

read more...

Singapore HSA Releases Best Practices Guide for Medical Device Cybersecurity

Singapore’s HSA Medical Devices Cluster previously released a draft Best Practices Guide for Medical Device Cybersecurity for stakeholder consultation. The …

read more...

Singapore HSA Revises Voluntary Notification Process for Complementary Health Products

Singapore’s Health Sciences Authority (HSA) revised the Voluntary Notification System (VNS) for Complementary Health Products (CHP), replacing the previous HSA’s …

read more...

Singapore HSA Announces Regulatory Updates for Medical Devices IVDs

Singapore HSA has announced below medical devices regulatory changes related to IVDs, effective 2 June 2026. 1. Change in risk …

read more...

Singapore HSA Updates Post-marketing Vigilance Requirements for Therapeutic Products and CTGTP

Singapore HSA updated Guidance for Post-marketing Vigilance Requirements for Therapeutic Products and Cell, Tissue and Gene Therapy Products (CTGTP), effective …

read more...

Singapore HSA Announces eCTD Format Officially Accepted for Therapeutic Products Regulatory Dossier Submission

Singapore HSA announces that electronic Common Technical Document (eCTD) format will be officially accepted for Therapeutic Products regulatory dossier submission …

read more...

Singapore HSA Updates Guidance on CTGTP Registration and Variation Applications

Health Sciences Authority (HSA) has updated the Guidance on Cell, Tissue or Gene Therapy Product (CTGTP) Registration and Variation Applications …

read more...

Singapore HSA and Malaysia MDA Jointly Launches Medical Device Regulatory Reliance Programme

The Medical Device Authority (MDA) of Malaysia and the Health Sciences Authority (HSA) of Singapore signed a Memorandum of Understanding …

read more...

Singapore HSA Updates Guidance on Product Defect Reporting and Recall Procedures for Therapeutic Products and CTGTP

As part of HSA’s ongoing initiative to improve regulatory efficiency and enhance clarity in Singapore’s regulatory requirements and processes, the …

read more...